0
Article |

Neuroblastoma Appearing as Protein-Losing Enteropathy FREE

JEFFREY S. GERDES, MD; AUBREY J. KATZ, MD
Am J Dis Child. 1982;136(11):1024-1025. doi:10.1001/archpedi.1982.03970470068017.
Text Size: A A A
Published online

A variety of malignant neoplasms have been reported to cause protein-losing enteropathy (PLE).1 Neuroblastomas are known to cause chronic diarrhea by poorly understood mechanisms of neurohumoral effects on bowel motility and secretions,2 but this tumor is generally not associated with PLE. We have recently seen an unusual case in which a neuroblastoma caused secondary intestinal lymphangiectasia and PLE.

Report of a Case.—An 8-month-old female infant was admitted to Children's Hospital Medical Center, Boston, with chronic diarrhea, periorbital edema, and abdominal distention. The infant had initially thrived on a cow's milk–based formula, and cereals had been introduced at 2 months of age. Three weeks before admission, she had the sudden onset of diarrhea, with ten watery, nonbloody stools per day that persisted despite formula changes. Five days before admission, she had the onset of progressive periorbital swelling.

The infant was pale and chronically ill appearing with a protuberant

REFERENCES

Waldmann TA:  Protein-losing enteropathy . Gastroenterology 1966;;50:422-443.
Pochedly C: Neuroblastoma . Acton, Mass, Publishing Sciences Group Inc, 1976;, pp 79-81, 226.
Waldmann TA, Broder S, Strober W:  Protein-losing enteropathy in malignancy . Curr Concepts Nutr 1977;;6:105-115.
Waldmann TA, Broder S, Strober W:  Protein-losing enteropathies in malignancy . Ann NY Acad Sci 1974;;230:306-316.
Schussheim A:  Protein-losing enteropathies in children . Am J Gastroenterol 1972;;58:124-132.
Weiden P, Blaese M, Strober W, et al:  Impaired lymphocyte transformation in intestinal lymphangiectasia: Evidence for at least two functionally distinct lymphocyte populations in man . J Clin Invest 1972;;51:1319-1325.
Strober W, Wochner RD, Carbone PP, et al:  Intestinal lymphangiectasia: A protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia, and impaired homograft rejection . J Clin Invest 1967;;46:1643-1654.
Holt PR:  Dietary treatment of protein loss in intestinal lymphangiectasia . Pediatrics 1964;; 34:629.
Vardy PA, Lebenthal E, Schwachman H:  Intestinal lymphangiectasia: A reappraisal . Pediatrics 1975;;55:842-851.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Waldmann TA:  Protein-losing enteropathy . Gastroenterology 1966;;50:422-443.
Pochedly C: Neuroblastoma . Acton, Mass, Publishing Sciences Group Inc, 1976;, pp 79-81, 226.
Waldmann TA, Broder S, Strober W:  Protein-losing enteropathy in malignancy . Curr Concepts Nutr 1977;;6:105-115.
Waldmann TA, Broder S, Strober W:  Protein-losing enteropathies in malignancy . Ann NY Acad Sci 1974;;230:306-316.
Schussheim A:  Protein-losing enteropathies in children . Am J Gastroenterol 1972;;58:124-132.
Weiden P, Blaese M, Strober W, et al:  Impaired lymphocyte transformation in intestinal lymphangiectasia: Evidence for at least two functionally distinct lymphocyte populations in man . J Clin Invest 1972;;51:1319-1325.
Strober W, Wochner RD, Carbone PP, et al:  Intestinal lymphangiectasia: A protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia, and impaired homograft rejection . J Clin Invest 1967;;46:1643-1654.
Holt PR:  Dietary treatment of protein loss in intestinal lymphangiectasia . Pediatrics 1964;; 34:629.
Vardy PA, Lebenthal E, Schwachman H:  Intestinal lymphangiectasia: A reappraisal . Pediatrics 1975;;55:842-851.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.